Laura Luberto
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
-
- Immunotherapy and Immune Responses
Papers in
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Luigi Aurisicchio (9 shared papers)Emanuele Marra (10 shared papers)Giuseppe Roscilli (8 shared papers)Fabio Palombo (2 shared papers)Giovanni Salvatori (2 shared papers)Mariano Maffei (1 shared paper)Gennaro Ciliberto (6 shared papers)Rita Mancini (3 shared papers)
- Journals
- Oncotarget (3 papers)Human Gene Therapy (2 papers)Nutrients (1 paper)Journal of Experimental & Clinical Cancer Research (1 paper)Nanoscale (1 paper)
- Partner nations
- ItalyUnited StatesIsrael
In The Last Decade
Laura Luberto
14 papers receiving 417 citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 130
- Immunology 74
- Oncology 88
- Biotechnology 31
- Radiology, Nuclear Medicine and Imaging 48
Countries citing papers authored by Laura Luberto
This map shows the geographic impact of Laura Luberto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Luberto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Luberto more than expected).
Fields of papers citing papers by Laura Luberto
This network shows the impact of papers produced by Laura Luberto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Luberto. The network helps show where Laura Luberto may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Luberto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 136 | |
| 2 | 2010 | 67 | |
| 3 | 2009 | 45 | |
| 4 | 2013 | 41 | |
| 5 | 2013 | 38 | |
| 6 | 2019 | 36 | |
| 7 | 2011 | 31 | |
| 8 | 2017 | 12 | |
| 9 | 2024 | 6 | |
| 10 | 2015 | 6 | |
| 11 | 2021 | 5 | |
| 12 | 2015 | 5 | |
| 13 | 2021 | 1 | |
| 14 | 2013 | 1 |
About Laura Luberto
Laura Luberto is a scholar working on Immunology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 14 papers that have together received 430 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Treatments and Mutations (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Virus-based gene therapy research (2 papers), Veterinary Oncology Research (1 paper) and Microbial Inactivation Methods (1 paper). The work is most often cited by research in Infectious Diseases (130 citations), Immunology (74 citations), Oncology (88 citations), Biotechnology (31 citations) and Radiology, Nuclear Medicine and Imaging (48 citations). Laura Luberto has collaborated with scholars based in Italy, United States and Israel. Frequent co-authors include Luigi Aurisicchio, Emanuele Marra, Giuseppe Roscilli, Fabio Palombo, Giovanni Salvatori, Mariano Maffei, Gennaro Ciliberto, Rita Mancini, Giuseppe Scala and Claudia De Vitis. Their work appears in journals such as Oncotarget, Human Gene Therapy, Nutrients, Journal of Experimental & Clinical Cancer Research and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.